Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310122231> ?p ?o ?g. }
- W4310122231 endingPage "9279" @default.
- W4310122231 startingPage "9264" @default.
- W4310122231 abstract "Multiple myeloma (MM) is an incurable plasma cell malignancy, while CAR-T therapy offers a new direction for the treatment of MM. Recently, signaling lymphocytic activation molecule family 3 (CD229), a cell surface immune receptor belonging to the signaling lymphocyte activating molecule family (SLAMF), is emerging as a CAR-T therapeutic target in MM. However, a clear role of CD229 in MM remains elusive. In this study, MM patients with elevated CD229 expression achieved poor prognosis by analyzing MM clinical databases. In addition, CD229 promoted MM cell proliferation in vitro as well as in xenograft mouse model in vivo. Mechanism study revealed that CD229 promoted MM cell proliferation by regulating the RAS/ERK signaling pathway. Further exploration employed co-immunoprecipitation coupled with mass spectrometry to identify RASAL3 as an important downstream protein of CD229. Additionally, we developed a co-culture method combined with the immunofluorescence assay to confirm that intercellular tyrosine phosphorylation mediated self-activation of CD229 to activate RAS/ERK signaling pathway via interacting with RASAL3. Taken together, these findings not only demonstrate the oncogenic role of CD229 in MM cell proliferation, but also illustrate the potential of CD229 as a promising therapeutic target for MM treatment." @default.
- W4310122231 created "2022-11-30" @default.
- W4310122231 creator A5005005012 @default.
- W4310122231 creator A5028935285 @default.
- W4310122231 creator A5029900439 @default.
- W4310122231 creator A5032161199 @default.
- W4310122231 creator A5042685456 @default.
- W4310122231 creator A5045477256 @default.
- W4310122231 creator A5061233342 @default.
- W4310122231 creator A5072858878 @default.
- W4310122231 creator A5077604881 @default.
- W4310122231 creator A5090625691 @default.
- W4310122231 date "2022-11-28" @default.
- W4310122231 modified "2023-10-15" @default.
- W4310122231 title "CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation" @default.
- W4310122231 cites W1490835233 @default.
- W4310122231 cites W1520006748 @default.
- W4310122231 cites W1522096076 @default.
- W4310122231 cites W1572455992 @default.
- W4310122231 cites W1591605215 @default.
- W4310122231 cites W1641067856 @default.
- W4310122231 cites W1880977714 @default.
- W4310122231 cites W1965355458 @default.
- W4310122231 cites W1970527559 @default.
- W4310122231 cites W1981447363 @default.
- W4310122231 cites W1984036332 @default.
- W4310122231 cites W1987673135 @default.
- W4310122231 cites W2029783596 @default.
- W4310122231 cites W2045021130 @default.
- W4310122231 cites W2061650461 @default.
- W4310122231 cites W2078402197 @default.
- W4310122231 cites W2119379789 @default.
- W4310122231 cites W2119462367 @default.
- W4310122231 cites W2136685326 @default.
- W4310122231 cites W2146182770 @default.
- W4310122231 cites W2147525885 @default.
- W4310122231 cites W2148758597 @default.
- W4310122231 cites W2153034562 @default.
- W4310122231 cites W2155165473 @default.
- W4310122231 cites W2171019943 @default.
- W4310122231 cites W2330192606 @default.
- W4310122231 cites W2564638997 @default.
- W4310122231 cites W2732767128 @default.
- W4310122231 cites W2782625331 @default.
- W4310122231 cites W2810370339 @default.
- W4310122231 cites W2895269262 @default.
- W4310122231 cites W2916106108 @default.
- W4310122231 cites W2938158852 @default.
- W4310122231 cites W2983986966 @default.
- W4310122231 cites W3001361950 @default.
- W4310122231 cites W3005010617 @default.
- W4310122231 cites W3007045996 @default.
- W4310122231 cites W3010814983 @default.
- W4310122231 cites W3120924626 @default.
- W4310122231 cites W3153616697 @default.
- W4310122231 cites W3156535202 @default.
- W4310122231 cites W3158345122 @default.
- W4310122231 cites W3160362305 @default.
- W4310122231 cites W3163996220 @default.
- W4310122231 cites W3168702145 @default.
- W4310122231 cites W3172664640 @default.
- W4310122231 cites W3204235500 @default.
- W4310122231 cites W4206916329 @default.
- W4310122231 cites W4206980934 @default.
- W4310122231 cites W4211191410 @default.
- W4310122231 cites W4213268919 @default.
- W4310122231 doi "https://doi.org/10.18632/aging.204405" @default.
- W4310122231 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36445333" @default.
- W4310122231 hasPublicationYear "2022" @default.
- W4310122231 type Work @default.
- W4310122231 citedByCount "1" @default.
- W4310122231 countsByYear W43101222312023 @default.
- W4310122231 crossrefType "journal-article" @default.
- W4310122231 hasAuthorship W4310122231A5005005012 @default.
- W4310122231 hasAuthorship W4310122231A5028935285 @default.
- W4310122231 hasAuthorship W4310122231A5029900439 @default.
- W4310122231 hasAuthorship W4310122231A5032161199 @default.
- W4310122231 hasAuthorship W4310122231A5042685456 @default.
- W4310122231 hasAuthorship W4310122231A5045477256 @default.
- W4310122231 hasAuthorship W4310122231A5061233342 @default.
- W4310122231 hasAuthorship W4310122231A5072858878 @default.
- W4310122231 hasAuthorship W4310122231A5077604881 @default.
- W4310122231 hasAuthorship W4310122231A5090625691 @default.
- W4310122231 hasBestOaLocation W43101222311 @default.
- W4310122231 hasConcept C11960822 @default.
- W4310122231 hasConcept C1491633281 @default.
- W4310122231 hasConcept C185592680 @default.
- W4310122231 hasConcept C207001950 @default.
- W4310122231 hasConcept C502942594 @default.
- W4310122231 hasConcept C54355233 @default.
- W4310122231 hasConcept C55493867 @default.
- W4310122231 hasConcept C57074206 @default.
- W4310122231 hasConcept C62112901 @default.
- W4310122231 hasConcept C62478195 @default.
- W4310122231 hasConcept C71829478 @default.
- W4310122231 hasConcept C81885089 @default.
- W4310122231 hasConcept C86803240 @default.
- W4310122231 hasConcept C95444343 @default.